EcoDrugPlus

Protein Kinase C, Alpha, A

Ensembl ID : ENSELUG00000013993
Gene Symbol: PRKCAA
1 Cross references
212 Possible Orthologues:

Protein Kinase C, Delta A

Ensembl ID : ENSELUG00000006789
Gene Symbol: PRKCDA
1 Cross references
206 Possible Orthologues:

Protein Kinase C, Theta

Ensembl ID : ENSELUG00000006297
Gene Symbol: PRKCQ
1 Cross references
205 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSELUG00000004243
Gene Symbol: PRKD1
3 Cross references
214 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSELUG00000014993
Gene Symbol: PRKD3
4 Cross references
207 Possible Orthologues:

Protein Kinase, Dna-Activated, Catalytic Subunit

Ensembl ID : ENSELUG00000016495
Gene Symbol: PRKDC
1 Cross references
187 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSELUG00000015889
Gene Symbol: PPP3CA
4 Cross references
233 Possible Orthologues:

Protein Tyrosine Kinase 2

Ensembl ID : ENSELUG00000022774
Gene Symbol: PTK2
1 Cross references
247 Possible Orthologues:

Protein Tyrosine Phosphatase Non-Receptor Type 11

Ensembl ID : ENSELUG00000002590
Gene Symbol: PTPN11
3 Cross references
253 Possible Orthologues:

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSELUG00000013246
Gene Symbol: PTPRB
1 Cross references
201 Possible Orthologues:

Protein-Serine O-Palmitoleoyltransferase Porcupine

Ensembl ID : ENSELUG00000006906
Gene Symbol: LOC105013829
3 Cross references
197 Possible Orthologues:

Protein-Tyrosine Kinase 2-Beta

Ensembl ID : ENSELUG00000005179
Gene Symbol: LOC105007684
3 Cross references
196 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).